BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 122279
Published online Nov 27, 2026. doi: 10.4240/wjgs.122279
Figure 1
Figure 1 Cumulative recurrence-free survival in patients with hepatocellular carcinoma after resection based on albumin-bilirubin grade. ALBI: Albumin-bilirubin.
Figure 2
Figure 2 Nomogram for predicting postoperative recurrence-free survival in patients with hepatocellular carcinoma. AFP: Preoperative alpha-fetoprotein; ALBI: Albumin-bilirubin.
Figure 3
Figure 3 Time-dependent receiver operating characteristic curves for recurrence-free survival prediction. A: Training set; B: Validation set. AUC: Area under the curve.
Figure 4
Figure 4 Calibration curves for predicting recurrence-free survival. A: Training set for 1- and 2-year recurrence-free survival; B: Validation set for 1- and 2-year recurrence-free survival. RFS: Recurrence-free survival.


Write to the Help Desk